GLW
68
4
AKAM
62
6
NOV
48
3
CMI
56
5
WMT
63
-3
EQIX
62
3
EMN
72
2
O
28
-7
GS
69
4
COST
53
2
USB
47
4
CF
60
3
SBUX
44
3
CVX
40
2
PG
48
-3
DAL
66
2
WMB
56
-4
AN
55
6
PRGO
46
-2
PGR
65
-3
GLW
68
4
AKAM
62
6
NOV
48
3
CMI
56
5
WMT
63
-3
EQIX
62
3
EMN
72
2
O
28
-7
GS
69
4
COST
53
2
USB
47
4
CF
60
3
SBUX
44
3
CVX
40
2
PG
48
-3
DAL
66
2
WMB
56
-4
AN
55
6
PRGO
46
-2
PGR
65
-3
Financhill
Back

Amicus Therapeutics Quote, Financials, Valuation and Earnings

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48

FOLD
Amicus Therapeutics

Last Price:
11.22
Seasonality Move:
-7.74%

7 Day Trial

ALL ACCESS PASS

$ 7

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Amicus Therapeutics Price Quote

$11.22
+0.22 (+2%)
(Updated: September 20, 2024 at 3:20 PM ET)

Amicus Therapeutics Key Stats

Sell
48
Amicus Therapeutics (FOLD) is a Sell
Day range:
$10.98 - $11.17
52-week range:
$9.02 - $14.57
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.26
P/B ratio:
24.62%
Volume:
2.2M
Avg. volume:
2.3M
1-year change:
-14.73%
Market cap:
$3.3B
Revenue:
$399.4M
EPS:
$-0.39

How Much Does Amicus Therapeutics Make?

Is Amicus Therapeutics Growing As A Company?

  • What Is Amicus Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.34%
  • What Is Amicus Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Amicus Therapeutics Stock Price Performance

What Is Amicus Therapeutics 52-Week High & Low?

Amicus Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Amicus Therapeutics?

Is Amicus Therapeutics Cash Flow Positive?

  • What Is FOLD Cash Flow From Operations?
    Cash flow from operations (TTM) is -$41.9M
  • What Is Amicus Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $31.7M
  • What Is Amicus Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.6M

Amicus Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    FOLD return on invested capital is -22.81%
  • What Is Amicus Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -15.97%
  • What Is FOLD Return On Equity?
    ROE is a measure of profitability and is -89.45%

Amicus Therapeutics Earnings Date & Stock Price

Amicus Therapeutics Competitors

Amicus Therapeutics Dividend Yield

Amicus Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 283.63%
Revenue: 34.04% 4.47%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 17.25
Upside from Last Price: 56.82%

Major Shareholders

  • How many FOLD shares are owned by institutional investors?
    504.6M FOLD shares are owned by institutional investors
  • How many FOLD shares are owned by insiders?
    5.5M FOLD shares are owned by insiders